These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Reversal of desipramine toxicity in rats with polyclonal drug-specific antibody Fab fragments. Pentel PR, Ross CA, Landon J, Sidki A, Shelver WL, Keyler DE. J Lab Clin Med; 1994 Mar; 123(3):387-93. PubMed ID: 8133150 [Abstract] [Full Text] [Related]
4. Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments. Ochs HR, Smith TW. J Clin Invest; 1977 Dec; 60(6):1303-13. PubMed ID: 914999 [Abstract] [Full Text] [Related]
5. Pharmacokinetics and toxicity of high doses of antibody Fab fragments in rats. Pentel PR, Keyler DE, Gilbertson DG, Ruth G, Pond SM. Drug Metab Dispos; 1988 Dec; 16(1):141-5. PubMed ID: 2894943 [Abstract] [Full Text] [Related]
7. Redistribution of tricyclic antidepressants in rats using a drug-specific monoclonal antibody: dose-response relationship. Pentel PR, Keyler DE, Brunn GJ, Milavetz JM, Gilbertson DG, Matta SG, Pond SM. Drug Metab Dispos; 1991 Dec; 19(1):24-8. PubMed ID: 1673407 [Abstract] [Full Text] [Related]
8. Disposition of a monoclonal anti-phencyclidine Fab fragment of immunoglobulin G in rats. McClurkan MB, Valentine JL, Arnold L, Owens SM. J Pharmacol Exp Ther; 1993 Sep; 266(3):1439-45. PubMed ID: 8371148 [Abstract] [Full Text] [Related]
12. Immunoglobulin G, F(AB')2, and fab fragment uptake kinetics in isolated perfused rat liver and rat hepatic cells. Bazin-Redureau M, Gires P, Chapelle P, Martinet M, Scherrmann JM. Drug Metab Dispos; 1995 Dec; 23(12):1400-6. PubMed ID: 8689951 [Abstract] [Full Text] [Related]